These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25893521)

  • 1. The 21st Annual Prostate Cancer Foundation Scientific Retreat report.
    Miyahira AK; Simons JW; Soule HR
    Prostate; 2015 Aug; 75(11):1119-28. PubMed ID: 25893521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 23rd Annual Prostate Cancer Foundation Scientific Retreat report.
    Miyahira AK; Soule HR
    Prostate; 2017 Jul; 77(10):1093-1106. PubMed ID: 28503903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 24th Annual Prostate Cancer Foundation scientific retreat report.
    Miyahira AK; Soule HR
    Prostate; 2018 Sep; 78(12):867-878. PubMed ID: 29761524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 25th Annual Prostate Cancer Foundation Scientific Retreat Report.
    Miyahira AK; Soule HR
    Prostate; 2019 Sep; 79(12):1471-1486. PubMed ID: 31334865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 20th Annual Prostate Cancer Foundation Scientific Retreat report.
    Miyahira AK; Simons JW; Soule HR
    Prostate; 2014 Jun; 74(8):811-9. PubMed ID: 24719035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 22nd annual prostate cancer foundation scientific retreat report.
    Miyahira AK; Simons JW; Soule HR
    Prostate; 2016 Sep; 76(12):1037-52. PubMed ID: 27272144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 19th annual Prostate Cancer Foundation scientific retreat.
    Walia G; Pienta KJ; Simons JW; Soule HR
    Cancer Res; 2013 Aug; 73(16):4988-91. PubMed ID: 23536559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 30th Annual Prostate Cancer Foundation Scientific Retreat Report.
    Miyahira AK; Soule HR
    Prostate; 2024 Oct; 84(14):1271-1289. PubMed ID: 39021296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 29th Annual Prostate Cancer Foundation Scientific Retreat Report.
    Miyahira AK; Soule HR
    Prostate; 2024 Feb; 84(2):113-130. PubMed ID: 37915138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 26th Annual Prostate Cancer Foundation Scientific Retreat Report.
    Miyahira AK; Soule HR
    Prostate; 2021 Jan; 81(1):3-19. PubMed ID: 33085787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 27th Annual Prostate Cancer Foundation Scientific Retreat Report.
    Miyahira AK; Soule HR
    Prostate; 2021 Nov; 81(15):1107-1124. PubMed ID: 34469608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 28th Annual Prostate Cancer Foundation Scientific Retreat report.
    Miyahira AK; Soule HR
    Prostate; 2022 Oct; 82(14):1346-1377. PubMed ID: 35852016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prostate Cancer Foundation 16th Annual Scientific Retreat: meeting report.
    Rhodes KE; Simons JW; Soule HR
    Prostate; 2010 Jun; 70(8):916-20. PubMed ID: 20166134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy Meeting.
    Miyahira AK; Cheng HH; Abida W; Ellis L; Harshman LC; Spratt DE; Simons JW; Pienta KJ; Soule HR
    Prostate; 2017 Nov; 77(15):1478-1488. PubMed ID: 28925066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 17th Annual Prostate Cancer Foundation scientific retreat: meeting report.
    Ericson KR; Simons JW; Soule HR
    Prostate; 2011 Nov; 71(15):1616-20. PubMed ID: 21394742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy Meeting.
    Miyahira AK; Den RB; Carlo MI; de Leeuw R; Hope TA; Karzai F; McKay RR; Salami SS; Simons JW; Pienta KJ; Soule HR
    Prostate; 2019 Feb; 79(3):244-258. PubMed ID: 30381857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting.
    Miyahira AK; Lang JM; Den RB; Garraway IP; Lotan TL; Ross AE; Stoyanova T; Cho SY; Simons JW; Pienta KJ; Soule HR
    Prostate; 2016 Feb; 76(2):125-39. PubMed ID: 26477609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer.
    Sumanasuriya S; Omlin A; Armstrong A; Attard G; Chi KN; Bevan CL; Shibakawa A; IJzerman MJ; De Laere B; Lolkema M; Lorente D; Luo J; Mehra N; Olmos D; Scher H; Soule H; Stoecklein NH; Terstappen LWMM; Waugh D; de Bono JS
    Eur Urol Oncol; 2018 Jun; 1(2):151-159. PubMed ID: 31100240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond Seed and Soil: Understanding and Targeting Metastatic Prostate Cancer; Report From the 2016 Coffey-Holden Prostate Cancer Academy Meeting.
    Miyahira AK; Roychowdhury S; Goswami S; Ippolito JE; Priceman SJ; Pritchard CC; Sfanos KS; Subudhi SK; Simons JW; Pienta KJ; Soule HR
    Prostate; 2017 Feb; 77(2):123-144. PubMed ID: 27679977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of advanced and castration resistant prostate cancer.
    Gomella LG; Petrylak DP; Shayegan B
    Can J Urol; 2014 Apr; 21(2 Supp 1):1-6. PubMed ID: 24775717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.